E. Ronmark (Lulea, Sweden), N. Saad (London, United Kingdom), P. Adab (Birmingham, United Kingdom), T. Schikowski (Basel, Switzerland)
The prevalence of COPD in Annaba, Algeria: Results of the BOLD study
H. Hacene Cherkaski, F. Khalloufi, F. Atoui, R. Yakoubi, L. Gnatiuc, P. Burney, R. Benali (Annaba, Algeria; London, United Kingdom)
|   |
Polish Spirometry Day 2013 as a way to increase public awareness concerning the causes, course and consequences of chronic respiratory diseases
A. Badyda, P. Dabrowiecki, A. Doboszynska, A. Gayer, D. Mucha, A. Chcialowski (Warsaw, Olsztyn, Poland)
| |
Comorbidities in patients with COPD and their impact on COPD course
I. Kuprys-Lipinska, P. Kuna (Lodz, Poland)
| |
Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
S. Maio, S. Baldacci, M. Borbotti, F. Martini, P. Silvi, G. Sarno, S. Cerrai, A. Angino, A. P. Pala, G. Viegi (Pisa, Palermo, Italy)
| |
How long does a COPD exacerbation last? – Predictors for duration more than 3 weeks
G. Husebø, P. Bakke, M. Aanerud, J. Hardie, R. Grønseth, T. Eagan (Bergen, Norway)
| |
Differences in disease severity between combination treatments in a Swedish population
L. Ekerljung, A. Bjerg, J. Lötvall, B. Lundbäck (Gothenburg, Sweden)
| |
Characteristics of patients newly prescribed a long acting bronchodilator in the United Kingdom (UK)
S. Landis, K. Wurst, H. Le, H. Muellerova, K. Davis (Uxbridge, United Kingdom; Research Triangle Park, United States Of America; Wavre, Belgium)
| |
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
M. Di Martino, S. Cascini, N. Agabiti, L. Bauleo, U. Kirchmayer, D. Fusco, L. Pinnarelli, V. Belleudi, C. Voci, G. Formoso, R. Pisetlli, E. Patorno, M. Davoli, OUTPUL Study Group (Rome, Bologna, Italy; Boston, United States Of America)
| |
One-year mortality associated with COPD treatment: A comparison of tiotropium and long-acting beta-2-agonists
S. Cascini, U. Kirchmayer, N. Agabiti, M. Di Martino, G. Formoso, C. Voci, R. Pistelli, E. Patorno, M. Davoli, OUTPUL Study Group (Rome, Bologna, Italy; Boston, United States Of America)
| |
Causes of death in COPD patients in primary care setting - 6 years follow-up
R. Plywaczewski, J. Maciejewski, M. Bednarek, J. Zielinski, P. Sliwinski (Warsaw, Sierpc, Poland)
| |
Cormorbidities and ventilator therapy impact on mortality of COPD patients in German hospitals - an analysis of ICD statistics
B. Löh, D. von der Beck, M. Korfei, W. Seeger, A. Günther (Giessen, Germany)
| |
Cause-specific mortality in mild COPD: The Rotterdam Study
L. Lahousse, G. Joos, A. Hofman, B. Stricker, G. Brusselle (Ghent, Belgium; Rotterdam, Netherlands)
| |
Use of a USA population survey to describe tobacco exposure, respiratory symptoms, and chronic diseases among smokers
Y. Liu, R. Pleasants, J. Croft, A. Wheaton, K. Heidari, J. Ohar, M. Kraft, D. Mannino, C. Strange (Atlanta, Buies Creek, Durham, Columbia, Winston Salem, Lexington, Charleston, United States Of America)
| |
COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients
P. Rogliani, L. Calzetta, F. Romeo, S. Muscoli, M. G. Matera, M. Cazzola (Rome, Naples, Italy)
| |
COPD symptoms/diagnosis and smoking habits: A 25 yr population-based survey
G. Sarno, S. Maio, S. Baldacci, F. Martini, P. Silvi, S. Cerrai, A. Angino, M. Fresta, G. Viegi (Pisa, Palermo, Italy)
| |
Associations between severity of airflow obstruction and atherosclerosis: A cross-sectional study in Japan
H. Omori, M. Oda, A. Onoue, N. Higashi, Y. Ogata, T. Katoh (Kumamoto, Japan)
| |
The burden of obstructive lung disease (BOLD) methodology overestimates the prevalence of COPD: A 5-year follow-up study
B. Allwood, R. Gillespie, M. Bateman, H. Olckers, L. Taborda-Barata, G. Calligaro, R. Van Zyl-Smit, N. Beyers, E. Bateman (Cape Town, Stellenbosch, South Africa; Covilha, Portugal)
| |
COPD admissions in an urban environment: Factors influencing length of stay
T. Harries, P. Schofield, S. Crichton, H. Thornton, P. White (London, United Kingdom)
| |
Fatigue is related to decreased health status in COPD
C. Stridsman, L. Hedman, L. Skär, A. Lindberg (Luleå, Umeå, Sweden)
| |
The relationship of socioeconomic status to emphysema and airway wall thickness
M. Gjerdevik, T. Grydeland, A. Gulsvik, P. Bakke (Bergen, Norway)
| |